Skip to main content
. 2018 Jan 9;24(2):65–72. doi: 10.5761/atcs.oa.17-00128

Table 1. Clinical data of 36 cases.

Factors All cases (n = 36)

Age 57 ± 14 years (22–83 years)
Gender Male (n = 20)
  Female (n = 16)
BMI 23.1 ± 3.7 kg/m2
MD 4.1 ± 2.3 cm (1.2–9.0 cm)
   <3.0 cm (n = 17)
   3.0 ≤ MD < 5.0 cm (n = 8)
   5.0 ≤ MD < 7.0 cm (n = 8)
   ≥7.0 (n = 3)
Weight of resected specimens 72.5 ± 49.6 g (15–212 g)
   PT: 27.5 ± 18.1 g
   TT: 73.2 ± 44.4 g
   CR: 126.0 ± 76.0 g
Operation procedure PT (n = 5)
  TT (n = 27)
  CR (n = 4)
Operation time 176.9 ± 62.6 min (94–446 min)
   PT: 132.4 ± 40.1 min
   TT: 173.9 ± 41.1 min
   CR: 253 ± 133.0 min
Intraoperative blood loss 20.6 ± 30.3 g (0–143 g)
   PT: 40.6 ± 60.2 g
   TT: 16.9 ± 23.0 g
   CR: 21.0 ± 23.4 g
Number of skin incisions 1 (n = 11)
  2 (n = 19)
  ≥3 (n = 6)
WBC on POD 1 9708 ± 2307/μL
CRP on POD 1 2.5 ± 1.8 mg/dL
Duration of chest tube drainage 1.7 ± 1.0 days
Postoperative stay 5.9 ± 7.6 days
Pathological diagnoses Thymoma (n = 20) (with MG: n = 2)
  Simple thymic cyst (n = 4)
  Thymic carcinoma or carcinoid (n = 4)
  Malignant lymphoma (n = 3)
  Multilocular thymic cyst (n = 2)
  Bronchogenic cyst (n = 1)
  Lymphangioma (n = 1)
  Castleman disease (n = 1)

BMI: body mass index; PT: partial thymectomy; TT: total or subtotal thymectomy; CR: total or subtotal thymectomy with combined resection of the surrounding organs or tissues; WBC: the white blood cell count; CRP: C-reactive protein; POD: postoperative day; MG: myasthenia gravis; MD: maximum diameter